documents: FDA-2018-N-3771-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2018-N-3771-0001 FDA FDA-2018-N-3771 Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability Notice Notice of Availability 2018-11-19T05:00:00Z 2018 11 2018-11-19T05:00:00Z   2018-11-19T14:51:02Z 2018-25128 0 0 09000064838e674f

Links from other tables